Priority Date: 20.12.12 (GB 20120023025)

PREDICTION OF THE TREATMENT RESPONSE TO AN ANTI-EGFR MOLECULE IN COLORECTAL CANCER PATIENTS

  • Application ID: EP13815453
  • Status: GRANT OF PATENT INTENDED

Attorney

operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Maiwald Patentanwalts GmbH is specialised in C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 20.12.2012 - Priority Date (GB 20120023025)
  • 26.06.2014 - Publication A1 (WO2014095766)
  • 28.10.2015 - Publication A1 (EP2935620)

IPC Classification